Enrico Pierobon

Enrico Pierobon

Auto-generated profile, based on publicly available information

Enrico Pierobon

Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung, Planckstrasse 1, 64291, Darmstadt, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2026 in Life Sciences in Space Research
Verified
Journal Article
Open access
EPE. Pierobon
E. Pierobon
LLL. Lunati
L. Lunati
TWT. Wagner
T. Wagner
Marco DuranteMarco Durante
Marco Durante
CSChristoph Schuy
Christoph Schuy
Space radiation is one of the major obstacles to space exploration. If not mitigated, radiation can interact both with biological and electronic systems, inducing damage and posing significant risk to space missions. Countermeasures can only be studied effectively with ground-based accelerators that act as a proxy for space radiation. Following an in-silico design and optimization process, we have developed a galactic cosmic ray (GCR) simulator using a hybrid active-passive methodology. In this approach, the primary beam energy is actively switched and the beam interacts with specifically designed passive modulators. In this paper, we present the implementation of such a GCR simulator and its experimental microdosimetric characterization. Measuring the GCR field is of paramount importance, both before providing it to the user as a validated radiation field and for achieving the best possible radiation description. The issue is addressed in this paper by using a tissue equivalent proportional counter to measure radiation quality and by comparing experimental measurements with Monte Carlo simulations. In conclusion, we will demonstrate the GCR simulator's capability to reproduce a GCR field.

21 February 2026 in Life Sciences in Space Research
Verified
Journal Article
Open access
LLL. Lunati
L. Lunati
EPE. Pierobon
E. Pierobon
UWUli Weber
Uli Weber
TWT. Wagner
T. Wagner
TPT. Pfuhl
T. Pfuhl
CSChristoph Schuy
Christoph Schuy
High-energy heavy-ion particle accelerators have long served as proxies for the harsh space radiation environment, enabling both fundamental life-science research and applied testing of flight hardware. Traditionally, monoenergetic high-energy heavy-ion beams have been employed for practicality, providing valuable datasets that underpin radiation risk and predictive computational models. However, such beams cannot fully reproduce the mixed-field nature of space radiation, motivating the development of realistic analogs for improved risk assessment and countermeasure evaluation in preparation for future deep-space missions to Moon or Mars. Spearheaded by developments at the NASA Space Radiation Laboratory, the GSI Helmholtzzentrum für Schwerionenforschung, supported by the European Space Agency (ESA), has established advanced space radiation simulation capabilities in Europe. Here, we present the design, optimization, and in-silico benchmarking of GSI's hybrid active-passive Galactic Cosmic Ray (GCR) simulator, together with a computationally optimized phase-space particle source for Geant4, which is available to external users for their own simulation studies and experimental planning.

4 September 2026 in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
Verified
Journal Article
Closed access
EPE. Pierobon
E. Pierobon
MMM. Missiaggia
M. Missiaggia
FCFrancesco Giuseppe Cordoni
Francesco Giuseppe Cordoni
CTC. La Tessa
C. La Tessa

24 November 2025 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
GPGabriele Parisi
Gabriele Parisi
MMMarta Missiaggia
Marta Missiaggia
EPEnrico Pierobon
Enrico Pierobon
FCFrancesco Giuseppe Cordoni
Francesco Giuseppe Cordoni
EVEnrico Verroi
Enrico Verroi
CTChiara La Tessa
Chiara La Tessa
Objective. Proton therapy is increasingly used in oncology due to its enhanced biological effectiveness and precision in targeting tumour tissues. Accurately characterising the radiation quality is, therefore, fundamental. However, the role of fragments in proton therapy remains understudied, mainly due to their low frequency of occurrence and limited impact on the dose. The fragments generated, though, interact differently with biological tissues and may substantially affect the biological response. This work characterises the fragments field generated by a typical clinical proton beam using microdosimetry. Approach. Experiments and Monte Carlo simulations were carried out for this purpose, using a 70.2 MeV proton beam moderated by a lung-equivalent material. Main results. Fragments contributed around 2% to y ¯ F and over 60% to y ¯ D , underscoring their relevance. The detector structure critically influenced their measurement, highlighting the necessity of detector-specific interpretation of spectra when used for biological modelling. Significance. Our results stress the importance of fragment-aware approaches for accurately assessing radiation quality and predicting biological outcomes in proton therapy.